DEAN KNUDSON: Open Payments
NPI 1215980008 · ST LOUIS PARK, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 9 payments from 7 companies in 2025. Trend: 2023 $8,663 · 2024 $113 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: AUSTEDO XR, FANAPT, INGREZZA, CAPLYTA, REXULTI, ZURZUVAE, INVEGA SUSTENNA.
Industry payments across MN — which companies pay providers there.
